Inactive Instrument

Analyst Reco. EXPN BIOT Nasdaq Stockholm

Equities

SE0008348262

End-of-day quote Nasdaq Stockholm Other stock markets
- ^PTS	-

05-16	ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ExpreS2ion Biotech : Pareto Securities AS initiates equity research coverage of ExpreS2ion with a Buy rating and target price of 60 SEK per share	24/06/21	AQ
ExpreS2ion Biotech : Analysguiden announces new research report with the target price for ExpreS2ion increased to 49 SEK per share	22/04/21	AQ
ExpreS2ion Biotech : Analysguiden announces new research report with the target price for ExpreS2ion at 24 SEK per share	27/01/21	AQ
ExpreS2ion Biotech : Analysguiden raises its target price for ExpreS2ion to 24 SEK per share	03/09/20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer